NO132431B - - Google Patents
Download PDFInfo
- Publication number
- NO132431B NO132431B NO434/71A NO43471A NO132431B NO 132431 B NO132431 B NO 132431B NO 434/71 A NO434/71 A NO 434/71A NO 43471 A NO43471 A NO 43471A NO 132431 B NO132431 B NO 132431B
- Authority
- NO
- Norway
- Prior art keywords
- general formula
- coumarin
- pyridyl
- methyl
- reaction
- Prior art date
Links
- 239000000543 intermediate Substances 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 150000001844 chromium Chemical class 0.000 claims 1
- 125000000332 coumarinyl group Chemical class O1C(=O)C(=CC2=CC=CC=C12)* 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- 150000004775 coumarins Chemical class 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 6
- 150000008371 chromenes Chemical class 0.000 description 6
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 3
- -1 methyl-magnesium halide Chemical class 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- ZORDDOAHFBBJHY-UHFFFAOYSA-N 2,2,7-trimethyl-4-pyridin-4-ylchromen-5-ol Chemical compound N1=CC=C(C=C1)C1=CC(OC=2C=C(C=C(C12)O)C)(C)C ZORDDOAHFBBJHY-UHFFFAOYSA-N 0.000 description 2
- NWTCVOMCWGLPPY-UHFFFAOYSA-N 5-hydroxy-7-(3-methyloctan-2-yl)-4-pyridin-4-ylchromen-2-one Chemical compound C=1C(=O)OC2=CC(C(C)C(C)CCCCC)=CC(O)=C2C=1C1=CC=NC=C1 NWTCVOMCWGLPPY-UHFFFAOYSA-N 0.000 description 2
- XJBFXFKGOJQTOA-UHFFFAOYSA-N 5-hydroxy-7-methyl-4-pyridin-4-ylchromen-2-one Chemical compound OC1=C2C(=CC(OC2=CC(=C1)C)=O)C1=CC=NC=C1 XJBFXFKGOJQTOA-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229960000956 coumarin Drugs 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- OIPPWFOQEKKFEE-UHFFFAOYSA-N orcinol Chemical compound CC1=CC(O)=CC(O)=C1 OIPPWFOQEKKFEE-UHFFFAOYSA-N 0.000 description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 description 2
- 239000011736 potassium bicarbonate Substances 0.000 description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- DKSZLDSPXIWGFO-BLOJGBSASA-N (4r,4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid;hydrate Chemical compound O.OP(O)(O)=O.OP(O)(O)=O.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC DKSZLDSPXIWGFO-BLOJGBSASA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- YHUDSHIRWOVVCV-UHFFFAOYSA-N 2,2-dimethyl-7-(3-methyloctan-2-yl)-4-pyridin-4-ylchromen-5-ol Chemical compound C=1C(C)(C)OC2=CC(C(C)C(C)CCCCC)=CC(O)=C2C=1C1=CC=NC=C1 YHUDSHIRWOVVCV-UHFFFAOYSA-N 0.000 description 1
- LFAMTYOOZUPASP-UHFFFAOYSA-N 5-(3-methyloctan-2-yl)benzene-1,3-diol Chemical compound CCCCCC(C)C(C)C1=CC(O)=CC(O)=C1 LFAMTYOOZUPASP-UHFFFAOYSA-N 0.000 description 1
- CFNMUZCFSDMZPQ-GHXNOFRVSA-N 7-[(z)-3-methyl-4-(4-methyl-5-oxo-2h-furan-2-yl)but-2-enoxy]chromen-2-one Chemical compound C=1C=C2C=CC(=O)OC2=CC=1OC/C=C(/C)CC1OC(=O)C(C)=C1 CFNMUZCFSDMZPQ-GHXNOFRVSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000003874 central nervous system depressant Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- ANTSCNMPPGJYLG-UHFFFAOYSA-N chlordiazepoxide Chemical compound O=N=1CC(NC)=NC2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 ANTSCNMPPGJYLG-UHFFFAOYSA-N 0.000 description 1
- 229960004782 chlordiazepoxide Drugs 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229960004415 codeine phosphate Drugs 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000012084 conversion product Substances 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- NXPHGHWWQRMDIA-UHFFFAOYSA-M magnesium;carbanide;bromide Chemical compound [CH3-].[Mg+2].[Br-] NXPHGHWWQRMDIA-UHFFFAOYSA-M 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4433—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63080867A | 1967-04-14 | 1967-04-14 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO132431B true NO132431B (sv) | 1975-08-04 |
| NO132431C NO132431C (sv) | 1975-11-12 |
Family
ID=24528640
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO01398/68A NO128711B (sv) | 1967-04-14 | 1968-04-09 | |
| NO71434A NO132431C (sv) | 1967-04-14 | 1971-02-05 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO01398/68A NO128711B (sv) | 1967-04-14 | 1968-04-09 |
Country Status (8)
| Country | Link |
|---|---|
| AT (1) | AT276395B (sv) |
| CA (1) | CA931956A (sv) |
| DK (2) | DK126856B (sv) |
| ES (1) | ES352696A1 (sv) |
| FI (1) | FI51101C (sv) |
| IE (1) | IE32014B1 (sv) |
| NO (2) | NO128711B (sv) |
| SE (1) | SE343300B (sv) |
-
1968
- 1968-04-08 CA CA017015A patent/CA931956A/en not_active Expired
- 1968-04-08 IE IE402/68A patent/IE32014B1/xx unknown
- 1968-04-09 NO NO01398/68A patent/NO128711B/no unknown
- 1968-04-09 DK DK158468AA patent/DK126856B/da unknown
- 1968-04-10 SE SE4903/68A patent/SE343300B/sv unknown
- 1968-04-11 ES ES352696A patent/ES352696A1/es not_active Expired
- 1968-04-11 FI FI681030A patent/FI51101C/sv active
- 1968-04-12 AT AT363968A patent/AT276395B/de active
-
1969
- 1969-02-27 DK DK108769AA patent/DK127121B/da unknown
-
1971
- 1971-02-05 NO NO71434A patent/NO132431C/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES352696A1 (es) | 1969-07-16 |
| DK126856B (da) | 1973-08-27 |
| NO128711B (sv) | 1974-01-02 |
| NO132431C (sv) | 1975-11-12 |
| IE32014B1 (en) | 1973-03-21 |
| AT276395B (de) | 1969-11-25 |
| DK127121B (da) | 1973-09-24 |
| FI51101B (sv) | 1976-06-30 |
| IE32014L (en) | 1968-10-14 |
| CA931956A (en) | 1973-08-14 |
| FI51101C (sv) | 1976-10-11 |
| SE343300B (sv) | 1972-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0314315B2 (sv) | ||
| US2980699A (en) | Dihydropyranocoumarin derivatives and process for their production | |
| KR920000956B1 (ko) | 아줄렌 유도체의 제조방법 | |
| Harris et al. | Alkylations at the γ-Position of Acetoacetaldehyde and α-Benzylacetoacetaldehyde through their Dicarbanions | |
| NO132431B (sv) | ||
| Shimada et al. | Generation of 1, 3-Chalcogenaza-1, 3-butadienes by Thermal Cycloreversion of 2, 4, 6-Trisubstituted 6 H-1, 3, 5-Oxachalcogenazines | |
| Kaneko et al. | A Novel Synthesis of Revenine and Related Alkaloids by Means of a Photo-rearrangement Reaction of 4-Alkoxy-2-methylquinoline 1-Oxides | |
| Hori et al. | Stable 2-thianaphthalenes: synthesis and reactions with electrophiles | |
| Ogura et al. | The Reaction of Aminotropones with Diketene. I. On the Synthesis of 3-Acetyl-1-azaazulenes and Related Reactions | |
| Arens et al. | Condensation products of β‐ionone with 2‐methyl‐and 2, 4‐dimethylpyridine: An attempt to synthesize vitamin a | |
| US3227722A (en) | Process for the preparation of pyredine | |
| Balenovic et al. | Synthesis of Aminomethylglyoxal Derivatives | |
| Pavlik et al. | Photoisomerization of 4-hydroxypyrylium cations in concentrated sulfuric acid | |
| KR101491239B1 (ko) | 싸이오플라본의 헤테로고리 유도체의 제조 방법 | |
| Lin et al. | Synthesis of Some Isocoumarin Derivatives | |
| US4258211A (en) | 4-Aminoaliphatic-2,3,5,6-[dibenzobicyclo[5.1.0]octanes] and salts thereof | |
| Plescia et al. | Studies on the synthesis of heterocyclic compounds. Part II. Action of phosphorus oxychloride on N‐Methyl‐N‐1‐phenyl‐3‐methylpyrazol‐5‐yl)‐2‐acetamidobenzamide | |
| Nace et al. | Nor steroids. X. Synthesis of A-nor steroids via the Dieckmann condensation | |
| SU943240A1 (ru) | Способ получени производных 10-окси-10н-пиридо [2,3- @ ХРОМЕНОВ | |
| SU1038341A1 (ru) | Способ получени @ -арилиндолотриметинцианинов | |
| JPS59176234A (ja) | ｐ‐ニトロフエニル３−ブロモ−２，２−ジエトキシ−プロピオネート | |
| US2440219A (en) | Ech ce | |
| Augustinsson et al. | 0-Substituted Pyridine-iV-oxide Derivatives | |
| JPH04368375A (ja) | イソオキサゾール誘導体 | |
| Boltacheva et al. | Unusual transformations of lithium enolate of ethyl 4, 4, 4-trifluoro-3-oxobutanoate |